Table 1

Baseline characteristics and outcomes (effectiveness and safety) of the study population stratified according to compliance with top-tier AHA evidence for MT

VariableTotal number (n=583)Cases meeting top-tier AHA evidence for MT (n=349)*Cases not meeting top-tier AHA evidence for MT (n=234)†p Value
Baseline characteristic
 Mean±SD age, years62±1963±1862±190.552
 Male gender, n (%)289 (50%)165 (47%)124 (53%)0.176
 Median (IQR) pretreatment NIHSS score, points17 (12-21)17 (14–21)16 (9–21)0.006
 Pretreatment with IV thrombolysis, n (%)292 (50%)198 (57%)94 (40%)<0.001
 Median (IQR) onset to groin puncture time, min232 (170–325)191 (155–247)365 (251–451)<0.001
Effectiveness outcomes
 Median (IQR) groin to recanalization time, min40 (24–64)41 (24–61)41 (26–62)0.762
 Complete recanalization, n (%)403 (69%)249 (71%)154 (66%)0.156
 Median (IQR) relative reduction in NIHSS score at discharge,‡ %63 (26–88)75 (44–91)57% (13–85%)0.018
 mRS 0–2 at 3 months, n (%)§222 (44%)142 (47%)80 (39%)0.055
Safety outcome
 sICH, n (%)50 (9%)30 (9%)20 (9%)0.983
 Other serious complications,¶ n (%)29 (5%)21 (6%)8 (3%)0.157
  • Three-month mortality data were available in 510 patients. There were 73 cases with missing 3-month mortality data.

  • *Fulfilling criteria AHA Class I Level A recommendations.

  • †Not fulfilling criteria AHA Class I Level A recommendations.

  • ‡Relative reduction in NIHSS score at discharge was calculated as follows: [(Admission NIHSS – Discharge NIHSS)×100]/Admission NIHSS.

  • §Three-month functional outcome was available in 510 patients. There were 73 cases with missing 3-month follow-up data.

  • ¶Other complications including transient vasospasm, groin hematoma, vessel dissection and/or perforation.

  • AHA, American Heart Association; mRS, modified Rankin Scale; MT, mechanical thrombectomy; NIHSS, NIH Stroke Scale; sICH, symptomatic intracerebral hemorrhage.